Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study.

pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

1991 • 5,979 citations

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

1997 • 2,438 citations

Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.

1993 • 457 citations

Bcl-2 protein expression and long-term survival in breast cancer.

1994 • 404 citations

Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma.

1993 • 398 citations

Reduced E-Cadherin Expression is Associated With Invasiveness and Unfavorable Prognosis in Breast Cancer

1996 • 302 citations

Predictors of axillary lymph node metastases in patients with T1 breast carcinoma

1997 • 214 citations

Clinical and Biologic Prognostic Factors in Breast Cancer Diagnosed During Postmenopausal Hormone Replacement Therapy

1995 • 111 citations

Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up

1996 • 109 citations

Prognostic characteristics in breast cancers after hormone replacement therapy

1996 • 101 citations

Demonstration of oestrogen receptors in paraffin wax sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing.

1994 • 78 citations

Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas.

1993 • 76 citations

Breast carcinoma in women under the age of 50: Relationship between p53 immunostaining, tumour grade, and axillary lymph node status

1998 • 31 citations

Immunohistochemical demonstration of oestrogen and progesterone receptors in paraffin sections of breast carcinoma

1997 • 21 citations